3-Morpholino-sydnonimine-induced suppression of human neutrophil degranulation is not mediated by cyclic GMP, nitric oxide or peroxynitrite: Inhibition of the increase in intracellular free calcium concentration by N- morpholino-iminoacetonitrile, a metabolite of 3-morpholino-sydnonimine

Molecular Pharmacology

Volumn 51, Issue 5, 1997, Pages 882-888

  Kankaanranta, Hannu ^a   Knowles, Richard G ^b   Vuorinen, Pauli ^c   Kosonen, Outi ^a   Holm, Päivi ^a   Moilanen, Eeva ^a,c  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b GLAXOSMITHKLINE   (United Kingdom)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCURONIDASE; CYCLIC GMP; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LINSIDOMINE; N MORPHOLINO N NITROSAMINOACETONITRILE; NITRIC OXIDE; PEROXYNITRITE;

ARTICLE; CALCIUM CELL LEVEL; DEGRANULATION; DRUG EFFECT; DRUG MECHANISM; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0030999559     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.51.5.882     Document Type: Article

References (42)

1. Furchgott, R. F., and J. V. Zawadzki. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (Lond.) 288:373-376 (1980).
2. Knowles, R. G., and S. Moncada. Nitric oxide synthases in mammals. Biochem. J. 298:249-258 (1994).
3. Moncada, S., and E. A. Higgs. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 9:1319-1330 (1995).
4. Moilanen, E., and H. Vapaatalo. Nitric oxide in inflammation and immune response. Ann. Med. 27:359-367 (1995).
5. Feelisch, M. The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J. Cardiovasc. Pharmacol. 17(Suppl. 3):S25-S33 (1991).
6. Feelisch, M., and E. A. Noack. Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur. J. Pharmacol. 139:19-30 (1987).
7. Feelisch, M., and E. Noack. Nitric oxide (NO) formation from nitrovasodilators occurs independently of hemoglobin or non-heme iron. Eur. J. Pharmacol. 142:465-469 (1987).
8. Bohn, H., and K. Schönafinger. Oxygen and oxidation promote the release of nitric oxide from sydnonimines. J. Cardiovasc. Pharmacol. 14(Suppl. 11):S6-S12 (1989).
9. Feelisch, M., J. Ostrowski, and E. Noack. On the mechanism of NO release from sydnonimines. J. Cardiovasc. Pharmacol. 14(Suppl. 11):S13-S22 (1989).
10. Hogg, N., V. M. Darley-Usmar, M. T. Wilson, and S. Moncada. Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem. J. 281:419-424 (1992).
11. Beckman, J. S., T. W. Beckman, J. Chen, P. A. Marshall, and B. A. Freeman. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA 87:1620-1624 (1990).
12. Crow, J. P., and J. S. Beckman. The role of peroxynitrite in nitric oxide-mediated toxicity. Curr. Top. Microbiol. 196:57-73 (1995).
13. Belenky, S. N., R. A. Robbins, S. I. Rennard, G. L. Gossman, K. J. Nelson, and I. Rubinstein. Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro. J. Lab. Clin. Med. 122:388-394 (1993).
14. Wyatt, T. A., T. M. Lincoln, and K. B. Pryzwansky. Regulation of human neutrophil degranulation by LY-83583 and arginine: role of cGMP-dependent protein kinase. Am. J. Physiol. 265:C201-C211 (1993).
15. 4 release from human PMN may be mediated by cyclic GMP. Eicosanoids 3:243-245 (1990).
16. Schröder, H., P. Ney, I. Woditsch, and K. Schrör. Cyclic GMP mediates SIN-1 induced inhibition of human polymorphonuclear leukocytes. Eur. J. Pharmacol. 182:211-218 (1990).
17. Dembinska-Kiec, A., A. Zmuda, J. Marcinkiewicz, H. Sinzinger, and R. J. Gryglewski. Influence of no-donor (SIN-1) on functions of inflammatory cells. Agents Actions 32:37-40 (1991).
18. Siminiak, T., H. Wysocki, and P. Dylewicz. Evaluation of the effect of isosorbide dinitrate and molsidomine on neutrophil functions. J. Appl. Cardiol. 6:433-442 (1991).
19. Siminiak, T., D. Zozulinska, and H. Wysocki. Inhibition of polymorphonuclear neutrophil function by nitric oxide donor SIN-1 in vitro; relationship to the presence of platelets. Pharmacol. Commun. 2:217-224 (1992).
20. Wenzel-Seifert, K., J. Ervens, and R. Seifert. Differential inhibition and potentiation by cell-permeant analogues of cyclic AMP and cyclic GMP and NO-containing compounds of exocytosis in human neutrophils. Naunyn-Schmiedeberg's Arch. Pharmacol. 344:396-402 (1991).
21. Darius, H., L. Grodzinska, and J. Meyer. The effects of the nitric oxide donors molsidomine and SIN-1 on human polymorphonuclear leukocyte function in vitro and ex vivo. Eur. J. Clin. Pharmacol. 43:629-633 (1992).
22. Gaboury, J., R. C. Woodman, D. N. Granger, P. Reinhardt, and P. Kubes. Nitric oxide prevents leukocyte adherence: role of superoxide. Am. J. Physiol. 265:H862-H867 (1993).
23. Moilanen, E., P. Vuorinen, H. Kankaanranta, T. Metsä-Ketelä, and H. Vapaatalo. Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions. Br. J. Pharmacol. 109:852-858 (1993).
24. Pieper, G. M., G. A. Clarke, and G. J. Gross. Stimulatory and inhibitory action of nitric oxide donor agents vs. nitrovasodilators on reactive oxygen production by isolated polymorphonuclear leukocytes. J. Pharmacol. Exp. Ther. 269:451-456 (1994).
25. Clancy, R. M., J. Leszczynska-Piziak, and S. B. Abramson. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J. Clin. Invest. 90:1116-1121 (1992).
26. Kanner J, Harel S, and Granit R. Nitric oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin. Lipids 27:46-49 (1992).
27. Clancy, R., J. Leszczynska, A. Amin, D. Levartovsky, and S. B. Abramson. Nitric oxide stimulates ADP ribosylation of actin in association with the inhibition of actin polymerization in human neutrophils. J. Leukocyte Biol. 58:196-202 (1995).
28. Kankaanranta, H., E. Rydell, A.-S. Petersson, P. Holm, E. Moilanen, T. Corell, G. Karup, P. Vuorinen, S. B. Pedersen, A. Wennmalm, and T. Metsä-Ketelä. Nitric oxide-donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives. Br. J. Pharmacol. 117:401-406 (1996).
29. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440-3450 (1985).
30. Kankaanranta, H., and E. Moilanen. Flufenamic and tolfenamic acids inhibit calcium influx in human polymorphonuclear leukocytes. Mol. Pharmacol. 47:1006-1013 (1995).
31. Jiang, H., J. L. Colbran, S. H. Francis, and J. D. Corbin. Direct evidence for cross-activation of cGMP-dependent protein kinase by cAMP in pig coronary arteries. J. Biol. Chem. 267:1015-1019 (1992).
32. Lincoln, T. M., P. Komavilas, N. J. Boerth, L. A. MacMillan-Crow, and T. L. Cornwell. cGMP signaling through cAMP-and cGMP-dependent protein kinases. Adv. Pharmacol. 34:305-322 (1995).
33. Sutherland, E. W., G. A. Robison, and R. W. Butcher. Some aspects of the biological role of adenosine 3′,5′-monophosphate (cyclic AMP). Circulation 37:279-306 (1968).
34. Maeda, H., T. Akaike, M. Yoshida, and M. Suga. Multiple functions of nitric oxide in pathophysiology and microbiology: analysis by a new nitric oxide scavenger. J. Leukocyte Biol. 56:588-592 (1994).
35. Hogg, N. R. J. Singh, J. Joseph, F. Neese, and B. Kalyanaraman. Reactions of nitric oxide with nitronyl nitroxides and oxygen: prediction of nitrite and nitrate formation by kinetic simulation. Free Radical Res. 22:47-56 (1995).
36. Siegfried, M. R., J. Erhardt, T. Rider, X.-L. Ma, and A. M. Lefer. Cardio-protection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J. Pharmacol. Exp. Ther. 260:668-675 (1992).
37. Henry, Y., M. Lepoivre, J.-C. Drapier, C. Ducroqo, J.-L. Boucher, and A. Guissani. EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J. 7:1124-1134 (1993).
38. Huie, R. E., and S. Padmaja. The reaction of NO with superoxide. Free Radical Res. Commun. 18:195-198 (1993).
39. Beckman, J. S., Y. Z. Ye, P. G. Andersson, J. Chen, M. A. Accavitti, M. M. Tarpey, and C. R. White. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol. Chem. Hoppe-Seyler 375:81-08 (1994).
40. Ervens, J., and R. Seifert. Molsidomine inhibits the chemoattractant-induced respiratory burst in human neutrophils via a NO-independent mechanism. Biochem. Pharmacol. 44:637-644 (1992).
41. Snyderman, R., and R. J. Uhing. Chemoattractant stimulus-response coupling, in Inflammation: Basic Principles and Clinical Correlates (J. I. Gallin, I. M. Goldstein, and R. Snyderman, eds.). Raven Press, New York, 421-139 (1992).
42. Kankaanranta, H., E. Moilanen, K. Lindberg, and H. Vapaatalo. Pharmacological control of human polymorphonuclear leukocyte degranulation by fenamates and inhibitors of receptor-mediated calcium entry and protein kinase C. Biochem. Pharmacol. 50:197-203 (1995).